Spironolactone tablets, USP 50 mg, Rx only, 100 count bottle, Distributed By: Greenstone LLC, Peapack, NJ 07977, NDC: 59762-5012-1
Published November 27, 2013 · Recall initiated: September 4, 2013
Summary
FDA records drug Class II recall D-011-2014, published November 27, 2013 and initiated September 4, 2013. Recalling firm: Greenstone Llc; Status: Terminated; Reported quantity: 4848 bottles; Lot: Lot #: V121211, Exp 03/31/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Greenstone Llc
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: V121211, Exp 03/31/2017
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAmethylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only,February 4, 2026
- FDAVenlafaxine HCl Extended-Release Capsules, 150 mg, 90-count Unit of Use bottles, Rx only, Distributed by:June 18, 2014
- FDAGlipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by:February 12, 2014
- FDANifedipine, extended-release tablets, 90mg 100 count blister pack, Rx only, Distributed by: GREENSTONE LLC,January 22, 2014
- FDASpironolactone tablets, USP 25 mg, Rx only, 500 count bottle, Distributed By: Greenstone LLC, Peapack, NJNovember 27, 2013
- FDAMetoclopramide Injection, USP 10 mg (5mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., LakeNovember 27, 2013
Questions about this recall
Was Spironolactone tablets, USP 50 mg, Rx only, 100 count bottle, Distributed By: Greenstone LLC, Peapack, NJ 07977, NDC: 59762-5012-1 recalled?
Yes. FDA published recall D-011-2014 on November 27, 2013. Reported hazard: Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.
What should I do if I have this product?
Voluntary: Firm initiated · Letter